Posted by Joseph Griffin on Sep 27th, 2013
Investment analysts at Jefferies Group cut their target price on shares of BioScrip from $17.00 to $11.00 in a note issued to investors on Friday.
The firm currently has a “buy” rating on the stock. Jefferies Group’s target price indicates a potential upside of 24.43% from the company’s current price.
BioScrip traded up 0.68% during mid-day trading on Friday, hitting $8.84. The stockhad a trading volume of 1,737,298 shares. BioScrip has a 52-week low of $8.29 and a 52-week high of $17.62. The stock’s 50-day moving average is $11.92 and its 200-day moving average is $13.81. The company’s market cap is $599.2 million.